世界の治療用放射性同位元素市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)

GlobalInfoResearchが発行した調査報告書(GIR21MY17401)
◆英語タイトル:Global Therapeutic Radioisotopes Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
◆商品コード:GIR21MY17401
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2021年5月
◆ページ数:107
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2~3日)
◆調査対象地域:グローバル
◆産業分野:Pharma & Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥400,200見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥600,300見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

GlobalInfoResearch社の本調査レポートでは、治療用放射性同位元素の世界市場を広く調査・分析し、今後の市場展望をまとめております。治療用放射性同位元素の種類別市場規模(ラジウム-223、ルテチウム-177、ヨウ素-131、その他)、用途別市場規模(甲状腺、骨転移、リンパ腫、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Bayer、Novartis、China Isotope & Radiation、Dongcheng、Q BioMed、Curium Pharmaceuticals、Jubilant DraxImage、Lantheus、Spectrum Pharmaceuticals、Progenics Pharmaceuticals、International Isotopes
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:ラジウム-223、ルテチウム-177、ヨウ素-131、その他
・用途別分析2016年-2026年:甲状腺、骨転移、リンパ腫、その他
・治療用放射性同位元素の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・治療用放射性同位元素のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・治療用放射性同位元素のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・治療用放射性同位元素の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・治療用放射性同位元素の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
【レポートの概要】

The Therapeutic Radioisotopes market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Therapeutic Radioisotopes size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Therapeutic Radioisotopes market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Therapeutic Radioisotopes market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Radium-223
Lutetium-177
Iodine-131
Other

Market segment by Application can be divided into
Thyroid
Bone Metastasis
Lymphoma
Other

The key market players for global Therapeutic Radioisotopes market are listed below:
Bayer
Novartis
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Lantheus
Spectrum Pharmaceuticals
Progenics Pharmaceuticals
International Isotopes

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

【レポートの目次】

1 Market Overview
1.1 Therapeutic Radioisotopes Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Therapeutic Radioisotopes Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Radium-223
1.2.3 Lutetium-177
1.2.4 Iodine-131
1.2.5 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Therapeutic Radioisotopes Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Thyroid
1.3.3 Bone Metastasis
1.3.4 Lymphoma
1.3.5 Other
1.4 Global Therapeutic Radioisotopes Market Size & Forecast
1.4.1 Global Therapeutic Radioisotopes Sales in Value (2016-2026))
1.4.2 Global Therapeutic Radioisotopes Sales in Volume (2016-2026)
1.4.3 Global Therapeutic Radioisotopes Price by Type (2016-2026) & (USD/Unit)
1.5 Global Therapeutic Radioisotopes Production Capacity Analysis
1.5.1 Global Therapeutic Radioisotopes Total Production Capacity (2016-2026)
1.5.2 Global Therapeutic Radioisotopes Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Therapeutic Radioisotopes Market Drivers
1.6.2 Therapeutic Radioisotopes Market Restraints
1.6.3 Therapeutic Radioisotopes Trends Analysis
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer Therapeutic Radioisotopes Product and Services
2.1.4 Bayer Therapeutic Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Therapeutic Radioisotopes Product and Services
2.2.4 Novartis Therapeutic Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 China Isotope & Radiation
2.3.1 China Isotope & Radiation Details
2.3.2 China Isotope & Radiation Major Business
2.3.3 China Isotope & Radiation Therapeutic Radioisotopes Product and Services
2.3.4 China Isotope & Radiation Therapeutic Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Dongcheng
2.4.1 Dongcheng Details
2.4.2 Dongcheng Major Business
2.4.3 Dongcheng Therapeutic Radioisotopes Product and Services
2.4.4 Dongcheng Therapeutic Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Q BioMed
2.5.1 Q BioMed Details
2.5.2 Q BioMed Major Business
2.5.3 Q BioMed Therapeutic Radioisotopes Product and Services
2.5.4 Q BioMed Therapeutic Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Curium Pharmaceuticals
2.6.1 Curium Pharmaceuticals Details
2.6.2 Curium Pharmaceuticals Major Business
2.6.3 Curium Pharmaceuticals Therapeutic Radioisotopes Product and Services
2.6.4 Curium Pharmaceuticals Therapeutic Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Jubilant DraxImage
2.7.1 Jubilant DraxImage Details
2.7.2 Jubilant DraxImage Major Business
2.7.3 Jubilant DraxImage Therapeutic Radioisotopes Product and Services
2.7.4 Jubilant DraxImage Therapeutic Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Lantheus
2.8.1 Lantheus Details
2.8.2 Lantheus Major Business
2.8.3 Lantheus Therapeutic Radioisotopes Product and Services
2.8.4 Lantheus Therapeutic Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Spectrum Pharmaceuticals
2.9.1 Spectrum Pharmaceuticals Details
2.9.2 Spectrum Pharmaceuticals Major Business
2.9.3 Spectrum Pharmaceuticals Therapeutic Radioisotopes Product and Services
2.9.4 Spectrum Pharmaceuticals Therapeutic Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Progenics Pharmaceuticals
2.10.1 Progenics Pharmaceuticals Details
2.10.2 Progenics Pharmaceuticals Major Business
2.10.3 Progenics Pharmaceuticals Therapeutic Radioisotopes Product and Services
2.10.4 Progenics Pharmaceuticals Therapeutic Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 International Isotopes
2.11.1 International Isotopes Details
2.11.2 International Isotopes Major Business
2.11.3 International Isotopes Therapeutic Radioisotopes Product and Services
2.11.4 International Isotopes Therapeutic Radioisotopes Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Therapeutic Radioisotopes Sales by Manufacturer
3.1 Global Therapeutic Radioisotopes Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Therapeutic Radioisotopes Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Therapeutic Radioisotopes
3.4 Market Concentration Rate
3.4.1 Top 3 Therapeutic Radioisotopes Manufacturer Market Share
3.4.2 Top 6 Therapeutic Radioisotopes Manufacturer Market Share
3.5 Global Therapeutic Radioisotopes Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Therapeutic Radioisotopes Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Therapeutic Radioisotopes Market Size by Region
4.1.1 Global Therapeutic Radioisotopes Sales in Volume by Region (2016-2026)
4.1.2 Global Therapeutic Radioisotopes Revenue by Region (2016-2026)
4.2 North America Therapeutic Radioisotopes Revenue (2016-2026)
4.3 Europe Therapeutic Radioisotopes Revenue (2016-2026)
4.4 Asia-Pacific Therapeutic Radioisotopes Revenue (2016-2026)
4.5 South America Therapeutic Radioisotopes Revenue (2016-2026)
4.6 Middle East and Africa Therapeutic Radioisotopes Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Therapeutic Radioisotopes Sales in Volume by Type (2016-2026)
5.2 Global Therapeutic Radioisotopes Revenue by Type (2016-2026)
5.3 Global Therapeutic Radioisotopes Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Therapeutic Radioisotopes Sales in Volume by Application (2016-2026)
6.2 Global Therapeutic Radioisotopes Revenue by Application (2016-2026)
6.3 Global Therapeutic Radioisotopes Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Therapeutic Radioisotopes Sales by Type (2016-2026)
7.2 North America Therapeutic Radioisotopes Sales by Application (2016-2026)
7.3 North America Therapeutic Radioisotopes Market Size by Country
7.3.1 North America Therapeutic Radioisotopes Sales in Volume by Country (2016-2026)
7.3.2 North America Therapeutic Radioisotopes Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Therapeutic Radioisotopes Sales by Type (2016-2026)
8.2 Europe Therapeutic Radioisotopes Sales by Application (2016-2026)
8.3 Europe Therapeutic Radioisotopes Market Size by Country
8.3.1 Europe Therapeutic Radioisotopes Sales in Volume by Country (2016-2026)
8.3.2 Europe Therapeutic Radioisotopes Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Therapeutic Radioisotopes Sales by Type (2016-2026)
9.2 Asia-Pacific Therapeutic Radioisotopes Sales by Application (2016-2026)
9.3 Asia-Pacific Therapeutic Radioisotopes Market Size by Region
9.3.1 Asia-Pacific Therapeutic Radioisotopes Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Therapeutic Radioisotopes Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Therapeutic Radioisotopes Sales by Type (2016-2026)
10.2 South America Therapeutic Radioisotopes Sales by Application (2016-2026)
10.3 South America Therapeutic Radioisotopes Market Size by Country
10.3.1 South America Therapeutic Radioisotopes Sales in Volume by Country (2016-2026)
10.3.2 South America Therapeutic Radioisotopes Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Therapeutic Radioisotopes Sales by Type (2016-2026)
11.2 Middle East & Africa Therapeutic Radioisotopes Sales by Application (2016-2026)
11.3 Middle East & Africa Therapeutic Radioisotopes Market Size by Country
11.3.1 Middle East & Africa Therapeutic Radioisotopes Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Therapeutic Radioisotopes Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Therapeutic Radioisotopes Typical Distributors
12.3 Therapeutic Radioisotopes Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Therapeutic Radioisotopes Revenue by Type, (USD Million), 2021-2026
Table 2. Global Therapeutic Radioisotopes Revenue by Application, (USD Million), 2021-2026
Table 3. Bayer Basic Information, Manufacturing Base and Competitors
Table 4. Bayer Major Business
Table 5. Bayer Therapeutic Radioisotopes Product and Services
Table 6. Bayer Therapeutic Radioisotopes Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Major Business
Table 9. Novartis Therapeutic Radioisotopes Product and Services
Table 10. Novartis Therapeutic Radioisotopes Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 12. China Isotope & Radiation Major Business
Table 13. China Isotope & Radiation Therapeutic Radioisotopes Product and Services
Table 14. China Isotope & Radiation Therapeutic Radioisotopes Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Dongcheng Basic Information, Manufacturing Base and Competitors
Table 16. Dongcheng Major Business
Table 17. Dongcheng Therapeutic Radioisotopes Product and Services
Table 18. Dongcheng Therapeutic Radioisotopes Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Q BioMed Basic Information, Manufacturing Base and Competitors
Table 20. Q BioMed Major Business
Table 21. Q BioMed Therapeutic Radioisotopes Product and Services
Table 22. Q BioMed Therapeutic Radioisotopes Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Curium Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Curium Pharmaceuticals Major Business
Table 25. Curium Pharmaceuticals Therapeutic Radioisotopes Product and Services
Table 26. Curium Pharmaceuticals Therapeutic Radioisotopes Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Jubilant DraxImage Basic Information, Manufacturing Base and Competitors
Table 28. Jubilant DraxImage Major Business
Table 29. Jubilant DraxImage Therapeutic Radioisotopes Product and Services
Table 30. Jubilant DraxImage Therapeutic Radioisotopes Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Lantheus Basic Information, Manufacturing Base and Competitors
Table 32. Lantheus Major Business
Table 33. Lantheus Therapeutic Radioisotopes Product and Services
Table 34. Lantheus Therapeutic Radioisotopes Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Spectrum Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 36. Spectrum Pharmaceuticals Major Business
Table 37. Spectrum Pharmaceuticals Therapeutic Radioisotopes Product and Services
Table 38. Spectrum Pharmaceuticals Therapeutic Radioisotopes Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Progenics Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. Progenics Pharmaceuticals Major Business
Table 41. Progenics Pharmaceuticals Therapeutic Radioisotopes Product and Services
Table 42. Progenics Pharmaceuticals Therapeutic Radioisotopes Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. International Isotopes Basic Information, Manufacturing Base and Competitors
Table 44. International Isotopes Major Business
Table 45. International Isotopes Therapeutic Radioisotopes Product and Services
Table 46. International Isotopes Therapeutic Radioisotopes Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Global Therapeutic Radioisotopes Sales by Manufacturer (2019-2021e) & (K Units)
Table 48. Global Therapeutic Radioisotopes Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 49. Market Position of Manufacturers in Therapeutic Radioisotopes, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 50. Global Therapeutic Radioisotopes Production Capacity by Company, (K Units): 2020 VS 2021
Table 51. Head Office and Therapeutic Radioisotopes Production Site of Key Manufacturer
Table 52. Global Therapeutic Radioisotopes Sales by Region (2016-2021e) & (K Units)
Table 53. Global Therapeutic Radioisotopes Sales by Region (2021-2026) & (K Units)
Table 54. Global Therapeutic Radioisotopes Revenue by Region (2016-2021e) & (USD Million)
Table 55. Global Therapeutic Radioisotopes Revenue by Region (2021-2026) & (USD Million)
Table 56. Global Therapeutic Radioisotopes Sales by Type (2016-2021e) & (K Units)
Table 57. Global Therapeutic Radioisotopes Sales by Type (2021-2026) & (K Units)
Table 58. Global Therapeutic Radioisotopes Revenue by Type (2016-2021e) & (USD Million)
Table 59. Global Therapeutic Radioisotopes Revenue by Type (2021-2026) & (USD Million)
Table 60. Global Therapeutic Radioisotopes Price by Type (2016-2021e) & (USD/Unit)
Table 61. Global Therapeutic Radioisotopes Price by Type (2021-2026) & (USD/Unit)
Table 62. Global Therapeutic Radioisotopes Sales by Application (2016-2021e) & (K Units)
Table 63. Global Therapeutic Radioisotopes Sales by Application (2021-2026) & (K Units)
Table 64. Global Therapeutic Radioisotopes Revenue by Application (2016-2021e) & (USD Million)
Table 65. Global Therapeutic Radioisotopes Revenue by Application (2021-2026) & (USD Million)
Table 66. Global Therapeutic Radioisotopes Price by Application (2016-2021e) & (USD/Unit)
Table 67. Global Therapeutic Radioisotopes Price by Application (2021-2026) & (USD/Unit)
Table 68. North America Therapeutic Radioisotopes Sales by Country (2016-2021e) & (K Units)
Table 69. North America Therapeutic Radioisotopes Sales by Country (2021-2026) & (K Units)
Table 70. North America Therapeutic Radioisotopes Revenue by Country (2016-2021e) & (USD Million)
Table 71. North America Therapeutic Radioisotopes Revenue by Country (2021-2026) & (USD Million)
Table 72. North America Therapeutic Radioisotopes Sales by Type (2016-2021e) & (K Units)
Table 73. North America Therapeutic Radioisotopes Sales by Type (2021-2026) & (K Units)
Table 74. North America Therapeutic Radioisotopes Sales by Application (2016-2021e) & (K Units)
Table 75. North America Therapeutic Radioisotopes Sales by Application (2021-2026) & (K Units)
Table 76. Europe Therapeutic Radioisotopes Sales by Country (2016-2021e) & (K Units)
Table 77. Europe Therapeutic Radioisotopes Sales by Country (2021-2026) & (K Units)
Table 78. Europe Therapeutic Radioisotopes Revenue by Country (2016-2021e) & (USD Million)
Table 79. Europe Therapeutic Radioisotopes Revenue by Country (2021-2026) & (USD Million)
Table 80. Europe Therapeutic Radioisotopes Sales by Type (2016-2021e) & (K Units)
Table 81. Europe Therapeutic Radioisotopes Sales by Type (2021-2026) & (K Units)
Table 82. Europe Therapeutic Radioisotopes Sales by Application (2016-2021e) & (K Units)
Table 83. Europe Therapeutic Radioisotopes Sales by Application (2021-2026) & (K Units)
Table 84. Asia-Pacific Therapeutic Radioisotopes Sales by Region (2016-2021e) & (K Units)
Table 85. Asia-Pacific Therapeutic Radioisotopes Sales by Region (2021-2026) & (K Units)
Table 86. Asia-Pacific Therapeutic Radioisotopes Revenue by Region (2016-2021e) & (USD Million)
Table 87. Asia-Pacific Therapeutic Radioisotopes Revenue by Region (2021-2026) & (USD Million)
Table 88. Asia-Pacific Therapeutic Radioisotopes Sales by Type (2016-2021e) & (K Units)
Table 89. Asia-Pacific Therapeutic Radioisotopes Sales by Type (2021-2026) & (K Units)
Table 90. Asia-Pacific Therapeutic Radioisotopes Sales by Application (2016-2021e) & (K Units)
Table 91. Asia-Pacific Therapeutic Radioisotopes Sales by Application (2021-2026) & (K Units)
Table 92. South America Therapeutic Radioisotopes Sales by Country (2016-2021e) & (K Units)
Table 93. South America Therapeutic Radioisotopes Sales by Country (2021-2026) & (K Units)
Table 94. South America Therapeutic Radioisotopes Revenue by Country (2016-2021e) & (USD Million)
Table 95. South America Therapeutic Radioisotopes Revenue by Country (2021-2026) & (USD Million)
Table 96. South America Therapeutic Radioisotopes Sales by Type (2016-2021e) & (K Units)
Table 97. South America Therapeutic Radioisotopes Sales by Type (2021-2026) & (K Units)
Table 98. South America Therapeutic Radioisotopes Sales by Application (2016-2021e) & (K Units)
Table 99. South America Therapeutic Radioisotopes Sales by Application (2021-2026) & (K Units)
Table 100. Middle East & Africa Therapeutic Radioisotopes Sales by Country (2016-2021e) & (K Units)
Table 101. Middle East & Africa Therapeutic Radioisotopes Sales by Country (2021-2026) & (K Units)
Table 102. Middle East & Africa Therapeutic Radioisotopes Revenue by Country (2016-2021e) & (USD Million)
Table 103. Middle East & Africa Therapeutic Radioisotopes Revenue by Country (2021-2026) & (USD Million)
Table 104. Middle East & Africa Therapeutic Radioisotopes Sales by Type (2016-2021e) & (K Units)
Table 105. Middle East & Africa Therapeutic Radioisotopes Sales by Type (2021-2026) & (K Units)
Table 106. Middle East & Africa Therapeutic Radioisotopes Sales by Application (2016-2021e) & (K Units)
Table 107. Middle East & Africa Therapeutic Radioisotopes Sales by Application (2021-2026) & (K Units)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Therapeutic Radioisotopes Typical Distributors
Table 111. Therapeutic Radioisotopes Typical Customers
List of Figures
Figure 1. Therapeutic Radioisotopes Picture
Figure 2. Global Therapeutic Radioisotopes Sales Market Share by Type in 2020
Figure 3. Radium-223
Figure 4. Lutetium-177
Figure 5. Iodine-131
Figure 6. Other
Figure 7. Global Therapeutic Radioisotopes Sales Market Share by Application in 2020
Figure 8. Thyroid
Figure 9. Bone Metastasis
Figure 10. Lymphoma
Figure 11. Other
Figure 12. Global Therapeutic Radioisotopes Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 13. Global Therapeutic Radioisotopes Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. United States Therapeutic Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Canada Therapeutic Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Mexico Therapeutic Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Germany Therapeutic Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. France Therapeutic Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. United Kingdom Therapeutic Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Russia Therapeutic Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Italy Therapeutic Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. China Therapeutic Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Japan Therapeutic Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Korea Therapeutic Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. India Therapeutic Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Southeast Asia Therapeutic Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Australia Therapeutic Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Brazil Therapeutic Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Egypt Therapeutic Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Saudi Arabia Therapeutic Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. South Africa Therapeutic Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Turkey Therapeutic Radioisotopes Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Global Therapeutic Radioisotopes Sales (2016-2026) & (K Units)
Figure 34. Global Therapeutic Radioisotopes Production Capacity (2016-2026) & (K Units)
Figure 35. Global Therapeutic Radioisotopes Production Capacity by Geographic Region: 2020 VS 2021
Figure 36. Therapeutic Radioisotopes Market Drivers
Figure 37. Therapeutic Radioisotopes Market Restraints
Figure 38. Therapeutic Radioisotopes Market Trends
Figure 39. Global Therapeutic Radioisotopes Sales Market Share by Manufacturer in 2020
Figure 40. Global Therapeutic Radioisotopes Revenue Market Share by Manufacturer in 2020
Figure 41. Therapeutic Radioisotopes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 42. Top 3 Therapeutic Radioisotopes Manufacturer (Revenue) Market Share in 2020
Figure 43. Top 6 Therapeutic Radioisotopes Manufacturer (Revenue) Market Share in 2020
Figure 44. Global Therapeutic Radioisotopes Sales Market Share by Region (2016-2026)
Figure 45. Global Therapeutic Radioisotopes Revenue Market Share by Region (2016-2026)
Figure 46. North America Therapeutic Radioisotopes Revenue (2016-2026) & (USD Million)
Figure 47. Europe Therapeutic Radioisotopes Revenue (2016-2026) & (USD Million)
Figure 48. Asia-Pacific Therapeutic Radioisotopes Revenue (2016-2026) & (USD Million)
Figure 49. South America Therapeutic Radioisotopes Revenue (2016-2026) & (USD Million)
Figure 50. Middle East & Africa Therapeutic Radioisotopes Revenue (2016-2026) & (USD Million)
Figure 51. Global Therapeutic Radioisotopes Sales Market Share by Type (2016-2026)
Figure 52. Global Therapeutic Radioisotopes Revenue Market Share by Type (2016-2026)
Figure 53. Global Therapeutic Radioisotopes Price by Type (2016-2026) & (USD/Unit)
Figure 54. Global Therapeutic Radioisotopes Sales Market Share by Application (2016-2026)
Figure 55. Global Therapeutic Radioisotopes Revenue Market Share by Application (2016-2026)
Figure 56. Global Therapeutic Radioisotopes Price by Application (2016-2026) & (USD/Unit)
Figure 57. North America Therapeutic Radioisotopes Sales Market Share by Country (2016-2026)
Figure 58. North America Therapeutic Radioisotopes Revenue Market Share by Country (2016-2026)
Figure 59. North America Therapeutic Radioisotopes Sales Market Share by Type (2016-2026)
Figure 60. North America Therapeutic Radioisotopes Sales Market Share by Application (2016-2026)
Figure 61. Europe Therapeutic Radioisotopes Sales Market Share by Country (2016-2026)
Figure 62. Europe Therapeutic Radioisotopes Revenue Market Share by Country (2016-2026)
Figure 63. Europe Therapeutic Radioisotopes Sales Market Share by Type (2016-2026)
Figure 64. Europe Therapeutic Radioisotopes Sales Market Share by Application (2016-2026)
Figure 65. Asia-Pacific Therapeutic Radioisotopes Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Therapeutic Radioisotopes Revenue Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Therapeutic Radioisotopes Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Therapeutic Radioisotopes Sales Market Share by Application (2016-2026)
Figure 69. South America Therapeutic Radioisotopes Sales Market Share by Country (2016-2026)
Figure 70. South America Therapeutic Radioisotopes Revenue Market Share by Country (2016-2026)
Figure 71. South America Therapeutic Radioisotopes Sales Market Share by Type (2016-2026)
Figure 72. South America Therapeutic Radioisotopes Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Therapeutic Radioisotopes Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Therapeutic Radioisotopes Revenue Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Therapeutic Radioisotopes Sales Market Share by Type (2016-2026)
Figure 76. Middle East & Africa Therapeutic Radioisotopes Sales Market Share by Application (2016-2026)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source


【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の治療用放射性同位元素市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)(Global Therapeutic Radioisotopes Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆